Stephen C McCluski's Net Worth

$4.85 Million

Estimate Recalculated Sep 8, 2024 07:36PM EST

Who is Stephen C McCluski?

Stephen C McCluski has an estimated net worth of $4.85 Million. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., MONRO, INC., STANDARD MICROSYSTEMS CORP, BAUSCH & LOMB INC, and INDEVUS PHARMACEUTICALS INC.

SEC CIK

Stephen C McCluski's CIK is 0001188728

Past Insider Trading and Trends

2004 was Stephen C McCluski's most active year for acquiring shares with 17 total transactions. Stephen C McCluski's most active month to acquire stocks was the month of October. 2005 was Stephen C McCluski's most active year for disposing of shares, totalling 19 transactions. Stephen C McCluski's most active month to dispose stocks was the month of January. 2005 saw Stephen C McCluski paying a total of $3,520,835.20 for 102,040 shares, this is the most they've acquired in one year. In 2004 Stephen C McCluski cashed out on 107,865 shares for a total of $3,673,519.74, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ImmunoGen, Inc. (IMGN) No price found

Investor

Stephen C McCluski used to own units in Common Stock but no longer holds any shares there. From 2021 to 2024 Stephen C McCluski acquired a total of 10,000 shares in ImmunoGen, Inc. at a cost of $147,000.00, Stephen also disposed a total of 10,000 shares of ImmunoGen, Inc. equalling to $160,500.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
$15.38
-$13,500.00
0
Sep 13
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 9
Form 4
—
0
—
—
0
Nov 10
Form 4
—
0
—
—
0
Nov 11
Form 4
—
0
—
—
0
Nov 12
Form 4
—
0
—
—
0
Nov 13
Form 4
—
0
—
—
0
Nov 8
Form 4
—
0
—
—
0
Nov 16 - Nov 17
Form 4
—
0
—
—
0
Nov 11
Form 4
—
0
—
—
0
Nov 12
Form 4
—
0
—
—
0
Apr 25
Form 4
—
0
—
—
0
Apr 26
Form 3
—
0
—
—
0
No matching records found

MONRO, INC. (MNRO) Snapshot price: $25.28

Investor

Stephen C McCluski owns 10,159 units of Common Stock which is worth $256,819.52, 18,685 units of Restricted Stock Awards which is worth $472,356.80 and 23,622 units of Restricted Stock Award which is worth $597,164.16. From 2012 to 2024 Stephen C McCluski acquired a total of 53,622 shares in MONRO, INC. at a cost of $1,593,236.16, Stephen also disposed a total of 30,000 shares of MONRO, INC. equalling to $1,917,765.40.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+26.42%
4.94K
—
—
23.62K
Aug 13
Form 4
+25.10%
3.75K
—
—
18.68K
Aug 15
Form 4
+19.39%
2.43K
—
—
14.94K
Aug 16
Form 4
+23.14%
2.35K
—
—
12.51K
Aug 17
Form 4
—
0
$58.22
-$8,728.00
10.16K
Aug 6
Form 4
+33.95%
2.58K
—
—
10.16K
Aug 18
Form 4
+28.04%
1.66K
—
—
7.58K
Aug 13
Form 4
—
0
$64.56
-$261,037.40
5.92K
Feb 14
Form 4
+44.64%
1.83K
—
—
5.92K
Aug 14
Form 4
—
0
$49.99
-$110,500.00
4.09K
Feb 5
Form 4
+241.25%
2.9K
—
—
4.09K
Aug 15
Form 4
∞
1.2K
$46.45
$55,736.16
1.2K
Jul 25
Form 4
—
0
—
—
0
Aug 9
Form 4
—
0
—
—
0
Aug 4
Form 4
—
0
—
—
0
Aug 5
Form 4
—
0
—
—
0
Aug 6
Form 3
—
0
—
—
0
No matching records found

STANDARD MICROSYSTEMS CORP No price found

Investor

Stephen C McCluski used to own units in Common Stock but no longer holds any shares there. From 2008 to 2010 Stephen C McCluski acquired a total of 4,867 shares in STANDARD MICROSYSTEMS CORP, Stephen also disposed a total of 4,867 shares of STANDARD MICROSYSTEMS CORP equalling to $180,079.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.87K
$37.00
-$180,079.00
0
Aug 2
Form 4
+3.69%
173
—
—
4.87K
Jul 16
Form 4
+5.51%
245
—
—
4.69K
Apr 16
Form 4
+6.36%
266
—
—
4.45K
Jan 17
Form 4
+7.48%
291
—
—
4.18K
Oct 17
Form 4
+6.98%
254
—
—
3.89K
Jul 15
Form 4
+7.54%
255
—
—
3.64K
Apr 15
Form 4
+8.15%
255
—
—
3.38K
Jan 18
Form 4
+9.26%
265
—
—
3.13K
Oct 15
Form 4
+10.46%
271
—
—
2.86K
Jul 15
Form 4
+9.74%
230
—
—
2.59K
Apr 15
Form 4
+13.78%
286
—
—
2.36K
Jan 15
Form 4
+16.69%
297
—
—
2.08K
Oct 15
Form 4
+19.88%
295
—
—
1.78K
Jul 15
Form 4
+33.81%
375
—
—
1.48K
Apr 15
Form 4
+64.30%
434
—
—
1.11K
Jan 15
Form 4
∞
675
—
—
675
Oct 15
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Jul 10
Form 3
—
0
—
—
0
No matching records found

BAUSCH & LOMB INC No price found

Senior Vice President

Stephen C McCluski owns 23,609 units of Common Stock. Stephen C McCluski used to own units in Class B Stock but no longer holds any shares there.acquired a total of 132,479 shares in BAUSCH & LOMB INC at a cost of $2,358,089.48, Stephen also disposed a total of 151,348 shares of BAUSCH & LOMB INC equalling to $5,365,289.99.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 8
Form 4
+6.47%
1.44K
$51.53
-$35,452.64
23.61K
Apr 3
Form 4
∞
611
—
—
611
Feb 21
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Nov 7
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
May 10
Form 4
+22.68%
3.95K
—
—
21.37K
Feb 15
Form 4
—
0
—
—
0
Nov 9
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
$58.01
-$1,140,374.00
17.36K
Scheduled
Aug 10
Form 4
—
0
—
—
0
May 11
Form 4
-2.80%
-500.00
—
—
17.34K
May 2
Form 4
—
0
—
—
0
Feb 16
Form 4
-21.48%
-4.87K
$72.90
-$381,923.10
17.81K
Scheduled
Feb 15
Form 4
—
0
—
—
0
Jan 31
Form 4
-3.25%
-761.00
$66.21
-$50,382.00
22.68K
Jan 25
Form 4
+0.19%
33
$63.40
$2,092.20
17.44K
Jan 4
Form 4
—
0
$51.50
-$444,000.00
23.41K
Scheduled
Nov 10
Form 4
-17.60%
-5.00K
$60.90
-$304,500.00
23.41K
Scheduled
Nov 3
Form 4
+0.18%
31
$67.00
$2,077.00
17.41K
Oct 1
Form 4
—
0
—
—
0
Aug 18
Form 4
-13.69%
-4.50K
$61.50
-$276,750.00
28.37K
Scheduled
Aug 3
Form 4
+0.14%
24
$64.28
$1,542.72
17.37K
Jul 1
Form 4
—
0
—
—
0
May 12
Form 4
+0.17%
30
$61.67
$1,850.10
17.35K
Apr 1
Form 4
-1.20%
-400.00
$48.10
-$132,409.20
32.82K
Scheduled
Mar 8
Form 4
-2.07%
-702.00
$59.10
-$41,490.54
33.22K
Feb 26 - Feb 27
Form 4
—
0
—
—
0
Feb 18
Form 4
+2.28%
365
—
—
16.4K
Feb 16
Form 4
—
0
—
—
0
Feb 2
Form 4
-18.58%
-4.00K
—
—
17.52K
Jan 27
Form 4
+0.21%
33
$51.62
$1,703.46
16.03K
Jan 2
Form 4
—
0
—
—
37.52K
Dec 8
Form 4
-25.43%
-4.07K
$51.78
-$210,640.52
11.93K
Dec 8
Form 4
—
0
—
—
0
Nov 12
Form 4
+0.20%
32
$45.50
$1,456.00
16K
Oct 1
Form 4
—
0
—
—
0
Aug 29
Form 4
—
0
—
—
0
Aug 15
Form 4
—
0
—
—
0
Aug 1
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
No matching records found

INDEVUS PHARMACEUTICALS INC No price found

Investor

Stephen C McCluski used to own units in Common Stock but no longer holds any shares there.acquired a total of 18,000 shares in INDEVUS PHARMACEUTICALS INC, Stephen also disposed a total of 18,000 shares of INDEVUS PHARMACEUTICALS INC.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 23 - Feb 24
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
Apr 30
Form 4
—
0
—
—
0
Mar 8
Form 4
—
0
—
—
0
Mar 10
Form 4
—
0
—
—
0
Mar 10
No matching records found